BioXcel Therapeutics Gets Positive Recommendation for Serenity Trial
BioXcel Therapeutics’ independent Data Safety Monitoring Board (DSMB) recommended the continuation of the SERENITY At-Home Phase 3 safety trial...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Artificial Intelligence in Clinical Trials Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
BioXcel Therapeutics’ independent Data Safety Monitoring Board (DSMB) recommended the continuation of the SERENITY At-Home Phase 3 safety trial...
Atai Life Sciences and Beckley Psytech announced positive topline results from a Phase 2b trial of BPL-003 (intranasal mebufotenin)...
Rinri Therapeutics received approval from the UK MHRA to begin its first-in-human clinical trial for Rincell-1, a regenerative cell...
ReproNovo has initiated a Phase 2 clinical trial for RPN-001 (leflutrozole), an oral aromatase inhibitor designed to treat male...
Invivyd formed the SPEAR Study Group to investigate the potential of monoclonal antibody therapy for Long COVID and Post-Vaccination...
Instil Bio announced FDA clearance of its Investigational New Drug (IND) application for AXN-2510 (’2510), a PD-L1xVEGF bispecific antibody....
At the 2025 Veeva R&D and Quality Summit, Stephanie Bova, Digital Transformation Officer of Drug Development at Novo Nordisk,...
A recent multi-center clinical trial published in the European Journal of Pediatrics demonstrated the safety and efficacy of Vivos...
Entera Bio announced that data from its Phase 2 study of EB613, an oral PTH(1-34) treatment for osteoporosis, was...
Invivyd announced positive Phase 1/2 clinical trial data for VYD2311, its next-generation monoclonal antibody designed to prevent and treat...